Date post: | 24-Dec-2015 |
Category: |
Documents |
Upload: | marianna-parrish |
View: | 220 times |
Download: | 5 times |
Issues Concerning Clinical Outcomes in Long-Term Issues Concerning Clinical Outcomes in Long-Term Trials of Cellular Therapies for Cartilage Repair.Trials of Cellular Therapies for Cartilage Repair. May May 15, 200915, 2009 Gunnar Knutsen MD, PhDGunnar Knutsen MD, PhD
University Hospital North NorwayUniversity Hospital North Norway
Universities inUniversities in Norway Norway
Tromsø
Bergen
Trondheim
Oslo
Northern most University Hospital in the world
Norwegian RCT ACI versus Microfracture
Blinded histological evaluation: SR, Oswestry UK and VI Tromsø Norway
80 patients
40 patients in each group
RCTsRCTs
Rare in orthopaedic surgeryRare in orthopaedic surgery Low methodological qualityLow methodological quality What I have learned from our trial…What I have learned from our trial… Study designStudy design MethodsMethods Endpoints: Clinical benefit, Instruments Endpoints: Clinical benefit, Instruments
of measurements. of measurements. Histology, MRIHistology, MRI Design a new trial…Design a new trial…
MethodsMethods
ICRSICRS LysholmLysholm SF-36SF-36 TegnerTegner Second-look arthroscopySecond-look arthroscopy Standing radiographsStanding radiographs HistologyHistology Failures: Symptomatic non healing of Failures: Symptomatic non healing of
defect and new cartilage operationdefect and new cartilage operation Statistical M.: SPSS, level of sign. p<0.05Statistical M.: SPSS, level of sign. p<0.05
Macroscopic evaluation ICRS 2 years
p= 0,170
Normal: 12p
nearly normal: 11-8p
abnormal: 7-4p
severely abnormal: 3-1p
ICRS
1,00
Treatment
0
20
40
60
80
100
Lyspre
Lys1
Lys2
Lys5
Treatment: 1,00
2,00
Treatment
0,00
20,00
40,00
60,00
80,00
100,00
49
Lyspre
Lys1
Lys2
Lys5
Treatment: 2,00
ACI Micro
LYSHOLM
P=0.227 linear regression
1,00
Treatment
20
30
40
50
60
70PCSpre
PCS1
PCS2
PCS5
Treatment: 1,00
2,00
Treatment
10
20
30
40
50
60
70
65 65
PCSpre
PCS1
PCS2
PCS5
Treatment: 2,00
ACI Micro
PCS- Physical component SF-36
P= 0.068
Lin.regression
1,00
Treatment
0,00
20,00
40,00
60,00
80,00
100,00VASpre
VAS1
VAS2
VAS5
Treatment: 1,00
2,00
Treatment
0,00
20,00
40,00
60,00
80,00
100,00VASpre
VAS1
VAS2
VAS5
Treatment: 2,00
ACI Micro
VAS- Visual Analog pain Score
P=0.189Linear regression
0 10 20 30 40 50 60
Failure month
0,0
0,2
0,4
0,6
0,8
1,0
Cu
m S
urv
ival
SURVIVAL
TreatmentACI
M
77.5%
ACI Microfracture
Group 1
Group 2
Group 3
Group 4
h i
a
gf
edc
b
1. Hyaline predominantly2. Fibrocartilage- hyaline mixture3. Fibrocartilage4. Inadequate biopsies or no repair tissue, predominantly bone
d: polaraized light
Arrow: may or may not be repair
tissue
Histological Histological GradeGrade
NN No. of No. of Failures Failures
11 1010 0 (0)0 (0)
22 1616 3 (18.8 )3 (18.8 )
33 2929 6 (20.7)6 (20.7)
44 1212 3 (25)3 (25)
Crosstabulation Crosstabulation HistologyHistology
P=0.118
P=0.001
Radiographic results Radiographic results at 5 yrsat 5 yrs 25% reduced joint space (<4mm)25% reduced joint space (<4mm) 33.9% at least Kellgren 2 at five 33.9% at least Kellgren 2 at five
yearsyears No significant difference between No significant difference between
groupsgroups Significant association between OA Significant association between OA
and pain (Kellgren Lawrence and and pain (Kellgren Lawrence and VAS)VAS)
Age and activityAge and activity
Younger patients (less than 30 Younger patients (less than 30 yrs. old) in both groups have yrs. old) in both groups have significant better results.significant better results.
More active patients (Tegner) More active patients (Tegner) in both groups have also in both groups have also significantly better clinical significantly better clinical scores (Lysholm, VAS and SF scores (Lysholm, VAS and SF 36)36)
ACI-MACI-M
ACI: two-step procedure including ACI: two-step procedure including arthrotomyarthrotomy
Microfracture: Cells have less Microfracture: Cells have less protectionprotection
Cells from the bone-marrow my contribute to both repairs ?
Conclusion 1Conclusion 1
ACI and Microfracture resulted ACI and Microfracture resulted in similar clinical results in similar clinical results
Nine failures (22.5%) in both Nine failures (22.5%) in both groupsgroups
No significant difference in No significant difference in macroscopic or histological macroscopic or histological results and no correlation at this results and no correlation at this point between histology and point between histology and clinical outcomeclinical outcome
Conclusion 2Conclusion 2 Good quality repair-cartilage reduces risk Good quality repair-cartilage reduces risk
of failureof failure Microfracture: first line treatment for Microfracture: first line treatment for
defects located on medial or lateral defects located on medial or lateral femoral condylefemoral condyle
Younger and more active patients do Younger and more active patients do betterbetter
Improvements in surgical techniques Improvements in surgical techniques needed as well as in the field of cellular needed as well as in the field of cellular and molecular biologyand molecular biology
Clinical scoresClinical scores
KOOS: Patient –administered:10 minutesKOOS: Patient –administered:10 minutes Evaluates both short- and long-term Evaluates both short- and long-term
consequences of knee injuryconsequences of knee injury 42 items in 5 separately scored domains; 42 items in 5 separately scored domains;
Pain, other symptoms, ADL, Function in Pain, other symptoms, ADL, Function in Sport/Rec and knee related QOLSport/Rec and knee related QOL
Includes WOMAC (24 items) OA Index Includes WOMAC (24 items) OA Index (pain, function and stiffness)(pain, function and stiffness)
KOOS KOOS Knee injury and Osteoarthritis Outcome ScoreKnee injury and Osteoarthritis Outcome Score
Validated in several populationsValidated in several populations ACL. Knee arthroscopy, Meniscectomy, ACL. Knee arthroscopy, Meniscectomy,
TKR, ACITKR, ACI Correlation with SF-36. +++Correlation with SF-36. +++ KOOS is the recommended self-report KOOS is the recommended self-report
measure of pain, function and QOLmeasure of pain, function and QOL KOOS responiseveness +++ indicating KOOS responiseveness +++ indicating
fewer subjects needed to get fewer subjects needed to get significancesignificance
KOOSKOOS
Generally, the subscale QOL is the Generally, the subscale QOL is the most responsive, followed by the most responsive, followed by the subscale Pain and Sport and subscale Pain and Sport and Recration function.Recration function.
Symptoms and function the last Symptoms and function the last weekweek
5 boxes (score 0-4)5 boxes (score 0-4) 100 (normalized score)100 (normalized score)
IKDCIKDC
Demographic formDemographic form Current Health Asessment FormCurrent Health Asessment Form Subjective Knee Evaluation FormSubjective Knee Evaluation Form Knee History FormKnee History Form Surgical Documentation FormSurgical Documentation Form Knee Examination FormKnee Examination Form
Subjective Knee Evaluation Form - IKDCSubjective Knee Evaluation Form - IKDC
SymptomsSymptoms SportSport FunctionFunction
18 items18 items IKDC score max 100IKDC score max 100
KOOS versus SF-36KOOS versus SF-36
KOOS includes also sport/recreation and knee KOOS includes also sport/recreation and knee related quality of liferelated quality of life
SF-36 well accepted instrument in health SF-36 well accepted instrument in health research: 8 dimensions; role physical,bodily research: 8 dimensions; role physical,bodily pain,general health,vitality, social pain,general health,vitality, social functioning, role emotional and mental functioning, role emotional and mental health.health.
PCS- Physical Component SummariesPCS- Physical Component Summaries PCS the only significant difference at 2 years PCS the only significant difference at 2 years
in our studyin our study MCS- Mental Component Summaries MCS- Mental Component Summaries
OutcomesOutcomes
Primary or secondaryPrimary or secondary ““Soft”: Clinical outcomes: symptom Soft”: Clinical outcomes: symptom
reduction (incl pain) and function. reduction (incl pain) and function. Placebo, bias.. Patient based: KOOS best Placebo, bias.. Patient based: KOOS best instrument in my opinioninstrument in my opinion
Functional testing: One leg jumping…e.g.Functional testing: One leg jumping…e.g.
““Hard” –less bias: Failure, TKR (OA)Hard” –less bias: Failure, TKR (OA) ““Surrogate”: Histology, Arthroscopic Surrogate”: Histology, Arthroscopic
evaluation/probing, MRI, ultrasound, X-evaluation/probing, MRI, ultrasound, X-rays, rays,
Fibrocartilage repair Fibrocartilage repair versus hyalineversus hyalineBundles of collagen fibers, lying in random irregular manner. Cells more elongated and often more numerous.
Collagen type I
Homogenous matrix. Round or oval shape of the cells often surrounded by lacuna.
Collagen type II
Polarized light
MRIMRI
Quantitative MRIQuantitative MRI
Lozano et al JBJS (Am)2006;88:1349-1352.
Non invasive
MRI scoring systems
Use of blinded readers
Techniques improves..
Follow patients and evaluating repair site at different time points
RCTRCT
Power calculationPower calculation MulticenterMulticenter Randomization- difficult in surgeryRandomization- difficult in surgery Standardization of procedure Standardization of procedure
(Surgeons like to do it “my way”)(Surgeons like to do it “my way”) Clear Endpoints- we had too many and Clear Endpoints- we had too many and
they could have been better definedthey could have been better defined BlindingBlinding RehabilitationRehabilitation Control group: Non operativeControl group: Non operative
Remember..Remember..
Evidence: On top: RCT Level 1Evidence: On top: RCT Level 1 On bottom: Experts opinion Level 5On bottom: Experts opinion Level 5 However, needing a surgeon- you However, needing a surgeon- you
would like to have an expertwould like to have an expert Skills- fingertip feeling-intuition are Skills- fingertip feeling-intuition are
difficult to include in RCTsdifficult to include in RCTs Surgery is complexSurgery is complex Standardization of techniquesStandardization of techniques